Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine

Background: The aim of the present study was to assess the migraine outcome, in particular migraine disability, in chronic (CM) and high frequency episodic migraine (HFEM) patients in treatment with galcanezumab. Methods: The present study was conducted at the Headache Centre of Spedali Civili of Br...

Descripción completa

Detalles Bibliográficos
Autores principales: di Cola, Francesca Schiano, Bolchini, Marco, Caratozzolo, Salvatore, Ceccardi, Giulia, Cortinovis, Matteo, Liberini, Paolo, Rao, Renata, Padovani, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944445/
https://www.ncbi.nlm.nih.gov/pubmed/36810472
http://dx.doi.org/10.3390/neurolint15010017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944445/
https://www.ncbi.nlm.nih.gov/pubmed/36810472
http://dx.doi.org/10.3390/neurolint15010017

Ejemplares similares